Thought Leadership

Antitrust Issues with Biologics and Biosimilars in the U.S. and Europe

Speeches & Presentations

Michael Perry will be joining fellow panelists for a discussion on the comparisons and contrasts of antitrust issues in the United States and Europe associated with biologics and biosimilars.

For more on this program, please click the title link below:

Antitrust Issues with Biologics and Biosimilars in the U.S. and Europe

Read More

Related Professionals